venBio Global Strategic Fund IV, L.P. (CIK 1862109) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-10). Recent activity: Buy ATTO (2.3M shares), Buy ATTO (821,998 shares), Buy ATTO (665,147 shares), Buy ATTO (382,352 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-10 | Attovia Therapeutics, Inc. (ATTO) | 10% Owner | Buy | 2.3M | $0 |
| 2026-08-10 | Attovia Therapeutics, Inc. (ATTO) | 10% Owner | Buy | 821,998 | $0 |
| 2026-08-10 | Attovia Therapeutics, Inc. (ATTO) | 10% Owner | Buy | 665,147 | $0 |
| 2026-08-10 | Attovia Therapeutics, Inc. (ATTO) | 10% Owner | Buy | 382,352 | $6.5M |
来源：SEC Form 4 申报文件 · 截至 2026-08-10